Chair, President and CEO Sharon Mates sold $1.1M of Intra-Cellular Therapies, Inc.

Sold$1,062,408

$47.03Price

22,590Shares

−2%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Fri, Feb 24. Filed Mon, Feb 27, 7:59 PM ET, after the close. Not investment advice.